108 results on '"Paraskevas, George P."'
Search Results
2. SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia
3. Waist Circumference and Body Mass Index as Predictors of Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-Analysis
4. Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience
5. Neuropsychological profiles comparison between Multiple Sclerosis patients and Multiple Sclerosis patients with overlapping features of systemic lupus erythematosus
6. The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
7. The Dynamic Relationship between the Glymphatic System, Aging, Memory, and Sleep
8. Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
9. The Presence of a Zygomatic Nerve Plexus in a Cadaveric Specimen Without a Zygomatic Branch of the Facial Nerve
10. CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
11. Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
12. Dopamine transporter SPECT imaging in Parkinson’s disease and atypical Parkinsonism: a study of 137 patients
13. Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia
14. Clinical, Neuroimaging, and Genetic Markers in Cerebral Amyloid Angiopathy-Related Inflammation: A Systematic Review and Meta-Analysis
15. Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies
16. Recognizing Atypical Presentations of Alzheimer’s Disease: The Importance of CSF Biomarkers in Clinical Practice
17. Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
18. Expanding the spectrum of C9ORF72-related neurodegenerative disorders in the Greek population
19. Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia
20. Silent Pauses and Speech Indices as Biomarkers for Primary Progressive Aphasia
21. Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
22. Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
23. Autotaxin Activity in Chronic Subdural Hematoma: A Prospective Clinical Study
24. Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis
25. Neuronal and Neuroaxonal Damage Cerebrospinal Fluid Biomarkers in Autoimmune Encephalitis Associated or Not with the Presence of Tumor
26. Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response
27. The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
28. Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
29. Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis
30. Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?
31. Neurological manifestations of long-COVID syndrome: a narrative review
32. CADASIL in Greece: Mutational spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases
33. From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
34. Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
35. Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
36. Stopping “transient ischemic attacks” by antiplatelet withdrawal
37. Ocular flutter as the cardinal feature of anti-GM2 rhombencephalitis
38. Blood Biomarkers in Frontotemporal Dementia: Review and Meta-Analysis
39. The “hypointense substantia nigra” sign. A novel MRI marker of progressive supranuclear palsy
40. Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
41. Cerebrospinal fluid biomarker profiling in corticobasal degeneration: Application of the AT(N) and other classification systems
42. Diffuse glioma manifesting as normal pressure hydrocephalus: A potential pitfall in diagnosis-a case report
43. Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
44. Area postrema involvement in chronic lymphocytic inflammation with pontine perivascular enhancement
45. Lentiform fork sign in a patient with systemic lupus erythematosus
46. Hot cross bun sign and prominent cerebellar peduncle involvement in a patient with oculodentodigital dysplasia
47. Biomarker-based diagnosis of cognitive disorders in a case series
48. Cerebrospinal fluid biomarkers for cognitive disorders. An introductory overview
49. Left Ventricular Hypertrophy and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis
50. Cerebrospinal fluid amyloid beta and tau proteins in atypical Parkinsonism: a review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.